Balance Labs, Inc.
BLNC
$0.183
-$0.0095-4.94%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 233.75% | 216.22% | 180.23% | 118.16% | 11.85% |
| Gross Profit | -233.75% | -4,806.45% | -273.38% | -162.73% | -128.17% |
| SG&A Expenses | 40.53% | -53.80% | -66.29% | -64.77% | -72.48% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 133.08% | 19.67% | -2.87% | -28.91% | -56.94% |
| Operating Income | -133.08% | -60.50% | -196.53% | -480.88% | -410.53% |
| Income Before Tax | -38.39% | -20.04% | 20.65% | 35.11% | 50.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -38.39% | -20.04% | 20.65% | 35.11% | 50.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.39% | -20.04% | 20.65% | 35.11% | 50.34% |
| EBIT | -133.08% | -60.50% | -196.53% | -480.88% | -410.53% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -38.07% | -19.23% | 21.07% | 35.15% | 50.42% |
| Normalized Basic EPS | -46.46% | -17.59% | -33.33% | -22.99% | -15.12% |
| EPS Diluted | -21.50% | -7.51% | 25.09% | 36.69% | 50.00% |
| Normalized Diluted EPS | -46.46% | -17.59% | -33.33% | -22.99% | -15.12% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |